Frontiers in Immunology (Jun 2020)

Interleukins in Thyroid Cancer: From Basic Researches to Applications in Clinical Practice

  • Chuang Xi,
  • Guo-Qiang Zhang,
  • Zhen-Kui Sun,
  • Hong-Jun Song,
  • Chen-Tian Shen,
  • Xiao-Yue Chen,
  • Jian-Wen Sun,
  • Zhong-Ling Qiu,
  • Quan-Yong Luo

DOI
https://doi.org/10.3389/fimmu.2020.01124
Journal volume & issue
Vol. 11

Abstract

Read online

Inflammation is crucial to tumorigenesis and progression of many cancers. Inflammatory molecules in tumor microenvironment exert pro- or anti-tumor effects. Among them, interleukin, mainly produced by CD3+ and CD4+ T lymphocytes, is a class of small molecule proteins which play an important role in intercellular communication. Numerous studies have confirmed that interleukins are closely related to thyroid cancer. Interleukins regulate the proliferation and migration of thyroid cancer cells and they have prospects in discriminating benign and malignant thyroid diseases, predicting the risk of tumorigenesis, evaluating the prognosis and monitoring the recurrence of thyroid cancer. Besides, the effective application of interleukins in treatment of thyroid cancer has been confirmed by some cell and animal researches. The present review will introduce the potential mechanisms of interleukins in thyroid cancer and focus on the applications of interleukins in clinical practice of thyroid cancer, which will help update understanding of the progress of interleukins researches in thyroid cancer.

Keywords